retatrutide glp-1 gip glucagon receptor agonist The TRIUMPH-1 Phase 3 results just dropped on retatrutide. Here is what the numbers actually say. is a triple agonist. It targets GLP-1, GIP, and receptors. Ozempic targets one. Mounjaro Retatrutide vs. Tirzepatide: The Next-Gen

A network meta-analysis of 22 randomized controlled trials covering 2,258 participants found GLP-1 receptor agonists reduced lean mass by a mean of 0.86 kg , published in Metabolism

Scott HA, Gibson PG, Garg ML, Pretto JJ, Morgan PJ, Callister R, Wood LG

8 , bvae164 (2024)

Biol Psychiatry 79:489498 Klausen MK, Thomsen M, Wortwein G, Fink-Jensen A (2022) The role of glucagon-like peptide 1 (GLP-1) in addictive disorders

Dry Mouth and Dental Problems Dry mouth, also known as xerostomia, is primarily due to the decrease in estrogen levels, which can significantly reduce saliva production, leading to a dry feeling in the mouth and throat, says Carlson

Contrave : This non-GLP-1 medication works on appetite and reward pathways and has been shown to help quiet food noise